SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-021797
Filing Date
2021-02-12
Accepted
2021-02-12 15:26:21
Documents
1
Group Members
FORESITE CAPITAL FUND V, L.P.FORESITE CAPITAL MANAGEMENT IV, LLCFORESITE CAPITAL MANAGEMENT V, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm215137d5_sc13g.htm SC 13G 102671
  Complete submission text file 0001104659-21-021797.txt   104449
Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund IV, L.P. (Filed by) CIK: 0001704131 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Subject) CIK: 0001830487 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92181 | Film No.: 21626486
SIC: 2834 Pharmaceutical Preparations